120 related articles for article (PubMed ID: 9137133)
1. Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder.
Brawman-Mintzer O; Lydiard RB; Bradwejn J; Villarreal G; Knapp R; Emmanuel N; Ware MR; He Q; Ballenger JC
Am J Psychiatry; 1997 May; 154(5):700-2. PubMed ID: 9137133
[TBL] [Abstract][Full Text] [Related]
2. Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients.
van Megen HJ; Westenberg HG; den Boer JA; Haigh JR; Traub M
Psychopharmacology (Berl); 1994 Apr; 114(3):449-55. PubMed ID: 7855203
[TBL] [Abstract][Full Text] [Related]
3. Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses.
Abelson JL; Nesse RM
Biol Psychiatry; 1994 Jul; 36(2):73-83. PubMed ID: 7948449
[TBL] [Abstract][Full Text] [Related]
4. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects.
Abelson JL; Liberzon I; Young EA; Khan S
Arch Gen Psychiatry; 2005 Jun; 62(6):668-75. PubMed ID: 15939844
[TBL] [Abstract][Full Text] [Related]
5. Effect of time of preparation on pentagastrin-induced symptom, endocrine and cardiovascular responses.
Khan S; Briggs H; Abelson JL
Psychiatry Res; 2008 Mar; 158(2):141-6. PubMed ID: 18222546
[TBL] [Abstract][Full Text] [Related]
6. Discrimination between panic disorder and generalized anxiety disorder by 35% carbon dioxide challenge.
Verburg K; Griez E; Meijer J; Pols H
Am J Psychiatry; 1995 Jul; 152(7):1081-3. PubMed ID: 7793449
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the effects of intravenous pentagastrin on patients with social phobia, panic disorder and healthy controls.
McCann UD; Slate SO; Geraci M; Roscow-Terrill D; Uhde TW
Neuropsychopharmacology; 1997 Mar; 16(3):229-37. PubMed ID: 9138439
[TBL] [Abstract][Full Text] [Related]
8. The effects of central administration of the CCK-B receptor agonist pentagastrin on feeding and cortisol release in sheep.
Ebenezer IS; Parrott RF
Methods Find Exp Clin Pharmacol; 1996 May; 18(4):235-8. PubMed ID: 8803955
[TBL] [Abstract][Full Text] [Related]
9. Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers.
Benkelfat C; Bradwejn J; Meyer E; Ellenbogen M; Milot S; Gjedde A; Evans A
Am J Psychiatry; 1995 Aug; 152(8):1180-4. PubMed ID: 7625467
[TBL] [Abstract][Full Text] [Related]
10. Pentagastrin infusions in patients with panic disorder. II. Neuroendocrinology.
Abelson JL; Nesse RM; Vinik AI
Biol Psychiatry; 1994 Jul; 36(2):84-96. PubMed ID: 7524696
[TBL] [Abstract][Full Text] [Related]
11. Effects of the 5-HT3 antagonist, ondansetron, on the behavioral and physiological effects of pentagastrin in patients with panic disorder and social phobia.
McCann UD; Morgan CM; Geraci M; Slate SO; Murphy DL; Post RM
Neuropsychopharmacology; 1997 Dec; 17(6):360-9. PubMed ID: 9397424
[TBL] [Abstract][Full Text] [Related]
12. Anxiogenic effects of caffeine in patients with anxiety disorders.
Bruce M; Scott N; Shine P; Lader M
Arch Gen Psychiatry; 1992 Nov; 49(11):867-9. PubMed ID: 1444724
[TBL] [Abstract][Full Text] [Related]
13. Peptides and anxiety: a dose-response evaluation of pentagastrin in healthy volunteers.
McCann UD; Slate SO; Geraci M; Uhde TW
Anxiety; 1994-1995; 1(6):258-67. PubMed ID: 9160584
[TBL] [Abstract][Full Text] [Related]
14. Effect of ethinyl estradiol on the panic response to the panicogenic agent pentagastrin.
McManus K; Tait GR; Bellavance F; Le Mellédo JM
J Affect Disord; 2001 Oct; 66(2-3):273-9. PubMed ID: 11578682
[TBL] [Abstract][Full Text] [Related]
15. Effect of medroxyprogesterone pretreatment on pentagastrin-induced panic symptoms in females with panic disorder.
Le Mellédo J; Jhangri GS; Lott P; Tait GR; McManus K; Geddes M; Chrapko W; Lara N
Psychiatry Res; 2001 Apr; 101(3):237-42. PubMed ID: 11311926
[TBL] [Abstract][Full Text] [Related]
16. Pentagastrin-induced sleep panic attacks: panic in the absence of elevated baseline arousal.
Geraci M; Anderson TS; Slate-Cothren S; Post RM; McCann UD
Biol Psychiatry; 2002 Dec; 52(12):1183-9. PubMed ID: 12488064
[TBL] [Abstract][Full Text] [Related]
17. Impact of state and trait anxiety on the panic response to CCK-4.
Eser D; Wenninger S; Baghai T; Schüle C; Rupprecht R
J Neural Transm (Vienna); 2008 Jun; 115(6):917-20. PubMed ID: 18414777
[TBL] [Abstract][Full Text] [Related]
18. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings.
Bradwejn J; Koszycki D; Shriqui C
Arch Gen Psychiatry; 1991 Jul; 48(7):603-10. PubMed ID: 2069490
[TBL] [Abstract][Full Text] [Related]
19. Dose response of adrenocorticotropin and cortisol to the CCK-B agonist pentagastrin.
Abelson JL; Liberzon I
Neuropsychopharmacology; 1999 Oct; 21(4):485-94. PubMed ID: 10481831
[TBL] [Abstract][Full Text] [Related]
20. Somatic symptoms and physiologic responses in generalized anxiety disorder and panic disorder: an ambulatory monitor study.
Hoehn-Saric R; McLeod DR; Funderburk F; Kowalski P
Arch Gen Psychiatry; 2004 Sep; 61(9):913-21. PubMed ID: 15351770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
